Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology? (Q34192908)

31 July 2017

1 reference

title

Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology? (English)

1 reference

31 July 2017

0 references

0 references

0 references

Medana IM

1

1 reference

31 July 2017

Chaudhri G

series ordinal

2

1 reference

31 July 2017

Chan-Ling T

series ordinal

3

1 reference

31 July 2017

Hunt NH

series ordinal

4

1 reference

31 July 2017

1 April 2001

1 reference

Immunology & Cell Biology

31 July 2017

1 reference

31 July 2017

79

1 reference

31 July 2017

2

1 reference

31 July 2017

101-120

1 reference

Neurological sequelae of cerebral malaria in children

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cytokines and anti-disease immunity to malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cerebral malaria in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

T cell responses in acute falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Indicators of life-threatening malaria in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Acidosis in severe childhood malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Hypoglycaemia on and after admission in Kenyan children with severe malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cerebral malaria. A disseminated vasculomyelinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Magnetic resonance imaging of the brain in patients with cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Evidence of blood-brain barrier dysfunction in human cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Activated human retinal microglia under pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Retinal findings predictive of outcome in cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Retinal haemorrhages in Zambian children with cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Measures of capillary permeability in acute falciparum malaria: relation to severity of infection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Neurological manifestations of falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cerebral malaria: the sequestration hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

The cytokine theory of human cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Human cerebral malaria in Thailand: a clinico-pathological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Pathology of malaria in West Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Proposed link between cytokines, nitric oxide and human cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cerebral malaria in inbred mice. I. A new model and its pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Breakdown of the blood-brain barrier in murine cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Inability of Plasmodium vinckei-immune spleen cells to transfer protection to recipient mice exposed to vaccine‘vectors’or heterologous species of plasmodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Protective CD4+ T-cell lines raised against Plasmodium chabaudi show characteristics of either Th1 or Th2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

The role of TH1 and TH2 cells in a rodent malaria infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Immune effector mechanisms in malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Malaria and alterations in immune reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Soluble plasma IL-2 receptors and malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

'Original antigenic sin', T cell memory, and malaria sporozoite immunity: an hypothesis for immune evasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

High frequency of malaria-specific T cells in non-exposed humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

The importance of T cell homing and the spleen in reaching a balance between malaria immunity and immunopathology: the moulding of immunity by early exposure to cross-reactive organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Histological changes in the spleen and liver of C57BL/6 and A/J mice during Plasmodium chabaudi AS infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Alterations in erythrocyte membrane phospholipid organization due to the intracellular growth of the human malaria parasite,Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Comparisons between microvascular changes in cerebral and non-cerebral malaria in mice, using the retinal whole-mount technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

The hematopoietic cytokine, colony-stimulating factor 1, is also a growth factor in the CNS: congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Mechanism of rapid K(+)-induced swelling of mouse astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Induction and regulation of interleukin-6 gene expression in rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentofylline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Macrophages and microglia in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cellular forms and functions of brain microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Functional plasticity of microglia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Neuronal control of MHC class II inducibility in rat astrocytes and microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Interleukin 1 of the central nervous system is produced by ameboid microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Interleukin-1 stimulation of astroglial proliferation after brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Peptides released by ameboid microglia regulate astroglial proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Glial expression of cytokines in the brains of cerebrovascular disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Inducible expression of H-2 and Ia antigens on brain cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Expression of the histocompatibility glycoprotein HLA-DR in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Microglia are the major cell type expressing MHC class II in human white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Inflammatory cells, microglia and MHC class II antigen-positive cells in the spinal cord of Lewis rats with acute and chronic relapsing experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cerebral malaria in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cerebral malaria. On the nature and significance of vascular changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cytokine expression in the brain in human cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Early activation of microglia in the pathogenesis of fatal murine cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Human cerebral malaria: alpha-galactosyl antibodies in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Macrophage membrane glycoprotein binding of Griffonia simplicifolia I-B4 induces TNF-alpha production and a tumoricidal response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Roles of tumour necrosis factor in the illness and pathology of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

The involvement of TNF, IL-1 and IL-6 in the immune response to protozoan parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Circulating tumour necrosis factor alpha is not involved in the development of cerebral malaria in Plasmodium berghei-infected C57Bl mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Serum tumor necrosis factor associated with malaria in patients in the Solomon Islands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Tumor necrosis factor and disease severity in children with falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

TNF and Plasmodium berghei ANKA-induced cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Effects of endotoxin and dexamethasone on cerebral malaria in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Immune response to soluble exoantigens of Plasmodium falciparum may contribute to both pathogenesis and protection in clinical malaria: evidence from a longitudinal, prospective study of semi-immune African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Production of nitrite by neonatal rat microglial cells/brain macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Are reactive oxygen species involved in the pathogenesis of murine cerebral malaria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cytokines in malaria, pathology and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Immunological alterations in uncomplicated Plasmodium falciparum malaria. Relationship between parasitaemia and indicators of macrophage activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

T lymphocyte interferon-gamma production induced by Plasmodium falciparum antigen is high in recently infected non-immune and low in immune subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Role of immune mediators in the pathology of experimental murine cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cerebral malaria: mediators, mechanical obstruction or more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Low dosages of interleukin 1 protect mice against lethal cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cytokines and tumors of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cytokines in neurodegeneration and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Interleukin-1 beta inhibits Ca2+ channel currents in hippocampal neurons through protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Tumour necrosis factor, interleukin-6, and malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Significance of cytokine production and adhesion molecules in malarial immunopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Interleukin-10 modulates susceptibility in experimental cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Cerebral malaria: the unsolved riddle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Differential cellular accumulation of transforming growth factor-beta1, -beta2, and -beta3 in brains of patients who died with cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Ocular fundus findings in Malawian children with cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Astrocytes present myelin basic protein to encephalitogenic T-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00995.X

10.1046/J.1440-1711.2001.00995.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference